Dr. Schwabe brings 30+ years of Clinical Experience in the Pharmaceutical Industry  TARRYTOWN, NY - October 24, 2022 - PaxMedica, Inc. (Nasdaq: PXMD), a clinical-stage biopharmaceutical company focused on the development of anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms such as autism spectrum disorder… Read More..

-Signs Lease Agreement for 10 acres of Industrial Land in Ocoee, FL- -Currently Collecting Hurricane Ian Debris for Conversion into Leading Soil Moisture Products, HumiSoil® and XLR8 Bio®, using Patented VRM Biologik Technology- NEW YORK, NY - October 24, 2022 - The Sustainable Green Team LTD (OTCMKTS: SGTM), an industry-leading wholesale manufacturer and… Read More..

Toronto, Ontario and Cambridge, MA, Oct. 12, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic misfolded proteins implicated in the development of neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS)… Read More..